Smilow Cancer Hospital at Glastonbury — Glastonbury, Connecticut

Smilow Cancer Hospital at Glastonbury is a clinical research site located in Glastonbury, Connecticut, United States 06033.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Smilow Cancer Hospital at Glastonbury has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Metastatic Breast Cancer, HER2-positive Metastatic Breast Cancer.

Sponsors: American Society of Clinical Oncology, Abramson Cancer Center at Penn Medicine.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Smilow Cancer Hospital at Glastonbury?

Smilow Cancer Hospital at Glastonbury has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Smilow Cancer Hospital at Glastonbury conducted?

Smilow Cancer Hospital at Glastonbury has 2 clinical trials on record, with 2 currently active. Their work covers Metastatic Breast Cancer, HER2-positive Metastatic Breast Cancer.

Is Smilow Cancer Hospital at Glastonbury accredited by Crixeo Health?

Smilow Cancer Hospital at Glastonbury has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Smilow Cancer Hospital at Glastonbury?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.